John Fucci
Patrimonio netto: 4 500 $ in data 31/07/2026
Patrimonio netto: 4 500 $ in data 31/07/2026
John Fucci's current job(s) include being a Partner at BIOS Capital Management LP since 2019 and a Board Member at SIRPant Immunotherapeutics, Inc. since 2021.
His former job(s) include being a Director at Lantern Pharma, Inc. and a Vice President at Steelhead Capital Management LLC from 2016 to 2019.
Mr. Fucci completed his undergraduate degree at Texas Christian University in 2014.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
Rein Therapeutics, Inc.
Rein Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops stapled peptide drugs 0,01% | 13/05/2026 | 6.106 ( 0,01% ) | 4 500 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
BIOS Capital Management LP
BIOS Capital Management LP Investment ManagersFinance BIOS Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and medical device sectors. It provides financing for early and later stage capital requirements. | Investitore di Private Equity | 01/05/2014 |
SIRPant Immunotherapeutics, Inc.
SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Direttore/Membro del Consiglio | 01/11/2021 |
| Società | Posizione | Fine |
|---|---|---|
| LANTERN PHARMA INC. | Direttore/Membro del Consiglio | 25/11/2019 |
Steelhead Capital Management LLC
Steelhead Capital Management LLC Investment ManagersFinance Acts as an alternative investment manager | Analista di Private Equity | 02/06/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Texas Christian University
Texas Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Steelhead Capital Management LLC
Steelhead Capital Management LLC Investment ManagersFinance Acts as an alternative investment manager | Finance |
BIOS Capital Management LP
BIOS Capital Management LP Investment ManagersFinance BIOS Partners invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and medical device sectors. It provides financing for early and later stage capital requirements. | Finance |
Lantern Pharma, Inc.
Lantern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer drug from advanced genomics and artificial intelligence | Health Technology |
SIRPant Immunotherapeutics, Inc.
SIRPant Immunotherapeutics, Inc. BiotechnologyHealth Technology Develops adoptive cell therapy | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale